StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.87−0.04 (-1.37%)

Close on Nov 13, 2026Market cap $235.47MP/E –Yield –

Lexeo Therapeutics statistics

68 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Q3 FY2026, expected soon
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$235.47M
$275.32M
Enterprise Value
$1.27M
$144.91M
PB Ratio
1.00
2.01
P/TBV Ratio
1.00
2.22

Share statisticsIndustry

Shares Change (YoY)
113.1%
10.8%
Shares Change (QoQ)
6.12%
0.49%
Float
81M
49M
Shares Held by Insiders
1.18%
11.6%
Shares Held by Institutions
109.1%
56.4%

Short sellingIndustry

Short Interest
17M
–
Short Interest Change
-2.94%
-0.80%
Short % of Float
21.0%
8.98%
Short % of Shares Outstanding
20.8%
6.30%
Days to Cover
12.73
5.16

Stock price statisticsIndustry

52-Week High
$10.99
–
52-Week Low
$2.55
–
20-Day Moving Average
$2.98
–
50-Day Moving Average
$3.38
–
200-Day Moving Average
$4.99
–
Average True Range (14)
$0.28
–
Price Change (1 Week)
-0.69%
-1.15%
Price Change (1 Month)
3.99%
-4.86%
Price Change (3 Months)
-42.4%
-21.1%
Price Change (6 Months)
-43.6%
-20.7%
Price Change (YTD)
-71.1%
-23.6%
Price Change (1 Year)
-68.8%
-22.7%
Price Change (3 Years)
-72.8%
-29.5%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.36
0.70
Relative Strength Index (14)
42.5
43.4
Volatility (1 Year)
70.9%
80.1%
Beta (5 Years)
2.16
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-46.8%
-50.3%
Return on Assets (ROA)
-40.5%
-40.6%
Return on Invested Capital (ROIC)
-5115.2%
-33.1%
Return on Capital Employed (ROCE)
-39.8%
-38.0%

Financial positionIndustry

Current Ratio
13.89
3.30
Quick Ratio
14.92
2.39
Interest Coverage
-1302.97
-6.31

EfficiencyIndustry

Profits Per Employee
-$1.48M
-$690.06K
Employee Count
59
75
WACC
15.9%
10.2%

Income statement (TTM)Industry

Operating Income
-$95.12M
-$21.40M
Pretax Income
-$86.97M
-$12.98M
Net Income
-$87.30M
-$22.39M
EBITDA
-$94.82M
-$17.04M
EPS (Diluted)
-$1.15
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$234.20M
$17.80M
Net Cash Per Share
$2.85
$0.80
Equity (Book Value)
$235.06M
$53.27M
Book Value Per Share
$2.86
$1.50
Tangible Book Value
$235.06M
$26.82M
Working Capital
$202.22M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$88.37M
-$12.35M
Capital Expenditures
-$331.00K
-$1.00M
Free Cash Flow
-$88.70M
-$18.21M
FCF Per Share
-$1.08
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-37.1%
-22.0%
FCF Yield
-37.7%
-9.44%
Buyback Yield
-10.7%
-0.76%
Shareholder Yield
-10.7%
0.00%

Taxes and interestIndustry

Interest Expense
$73.00K
$2.93M

Scores and fair valueIndustry

Altman Z-Score
4.50
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodLXEOS&P 500DifferenceLXEO per yearS&P 500 per year
1 month+4.7%-3.0%+7.8 pts
3 months-42.1%-2.8%−39.4 pts
Year to date-71.1%+11.5%−82.6 pts
1 year-68.1%+13.5%−81.5 pts
3 years-72.7%+77.7%−150.4 pts-35.1%+21.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

17M LXEO shares were sold short on Oct 30, 2026, down 2.9% from the previous report, or 21.01% of the shares available to trade. At recent volumes it would take 12.7 days to buy them back. Over the last 20 sessions, 50.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202617,037,063-2.9%1,338,37112.7
Oct 15, 202617,553,163-8.8%1,747,72910.0
Sep 30, 202619,246,976-6.7%2,129,6019.0
Sep 15, 202620,627,916+0.7%616,77833.4
Aug 31, 202620,485,477+0.0%763,91026.8
Aug 14, 202620,477,587+20.1%1,035,72019.8
Jul 31, 202617,054,582+4.3%1,010,87816.9
Jul 15, 202616,348,536+1.4%836,12319.6
Jun 30, 202616,129,164+14.5%1,150,33514.0
Jun 15, 202614,088,171+2.3%748,94718.8
May 29, 202613,775,211+4.3%793,54317.4
May 15, 202613,212,896+1.1%702,02218.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?